The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer

被引：349

作者：

Wang, Feng-Hua ^{[1
]}

Shen, Lin ^{[2
]}

Li, Jin ^{[3
]}

Zhou, Zhi-Wei ^{[4
]}

Liang, Han ^{[5
]}

Zhang, Xiao-Tian ^{[2
]}

Tang, Lei ^{[6
]}

Xin, Yan ^{[7
]}

Jin, Jing ^{[8
,9
,10
]}

Zhang, Yu-Jing ^{[11
]}

Yuan, Xiang-Lin ^{[12
]}

Liu, Tian-Shu ^{[13
]}

Li, Guo-Xin ^{[14
]}

Wu, Qi ^{[15
]}

Xu, Hui-Mian ^{[16
]}

Ji, Jia-Fu ^{[2
]}

Li, Yuan-Fang ^{[4
]}

Wang, Xin ^{[8
,9
,10
]}

Yu, Shan ^{[13
]}

Liu, Hao ^{[2
]}

Guan, Wen-Long ^{[1
]}

Xu, Rui-Hua ^{[1
]}

机构：

[1] Sun Yat Sen Univ, Dept Med Oncol, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China

[2] Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China

[3] Tongji Univ, Dept Oncol, Shanghai East Hosp, Sch Med, Shanghai 200120, Peoples R China

[4] Sun Yat Sen Univ, Dept Gastr Surg, Canc Ctr, Collaborat Innovat Ctr Canc Med,State Key Lab Onc, Guangzhou 510060, Guangdong, Peoples R China

[5] Tianjin Med Univ, Dept Gastr Canc, Key Lab Canc Prevent & Therapy,Canc Inst & Hosp, Tianjins Clin Res Canc Canc,Natl Clin Res Ctr Can, Tianjin 300060, Peoples R China

[6] Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Oncol,Med Imaging Dept, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China

[7] China Med Univ, Pathol Lab Gastrointestinal Tumor, Hosp 1, Shenyang 110001, Liaoning, Peoples R China

[8] Natl Canc Ctr, Dept Radiat Oncol, Beijing 100021, Peoples R China

[9] Chinese Acad Med Sci, Canc Hosp, Beijing 100021, Peoples R China

[10] Peking Union Med Coll, Beijing 100021, Peoples R China

[11] Sun Yat Sen Univ, Dept Radiotherapy, Collaborat Innovat Ctr Canc Med,Canc Ctr, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China

[12] Huazhong Univ Sci & Technol, Dept Med Oncol, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China

[13] Fudan Univ, Zhongshan Hosp, Dept Med Oncol, Shanghai 200032, Peoples R China

[14] Southern Med Univ, Dept Gen Surg, Nanfang Hosp, Guangzhou 510515, Guangdong, Peoples R China

[15] Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Oncol,Dept Endoscopy Ctr, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China

[16] China Med Univ, Dept Surg Oncol, Hosp 1, Shenyang 110001, Liaoning, Peoples R China

来源：

CANCER COMMUNICATIONS | 2019年 / 39卷

关键词：

Chinese Society of Clinical Oncology (CSCO); Gastric cancer; Diagnosis; Surgery; Neoadjuvant; Adjuvant; Radiotherapy; Chemotherapy; Targeted therapy; Immunotherapy; PHASE-III TRIAL; LYMPH-NODE METASTASIS; 3-DIMENSIONAL CONFORMAL RADIOTHERAPY; ENDOSCOPIC SUBMUCOSAL DISSECTION; INTENSITY-MODULATED RADIOTHERAPY; S-1 PLUS CISPLATIN; NEOADJUVANT CHEMOTHERAPY; GASTROESOPHAGEAL ADENOCARCINOMA; LIVER METASTASES; SURGICAL RESECTION;

D O I：

10.1186/s40880-019-0349-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

China is one of the countries with the highest incidence of gastric cancer. There are differences in epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment patterns, and drug selection between gastric cancer patients from the Eastern and Western countries. Non-Chinese guidelines cannot specifically reflect the diagnosis and treatment characteristics for the Chinese gastric cancer patients. The Chinese Society of Clinical Oncology (CSCO) arranged for a panel of senior experts specializing in all sub-specialties of gastric cancer to compile, discuss, and revise the guidelines on the diagnosis and treatment of gastric cancer based on the findings of evidence-based medicine in China and abroad. By referring to the opinions of industry experts, taking into account of regional differences, giving full consideration to the accessibility of diagnosis and treatment resources, these experts have conducted experts' consensus judgement on relevant evidence and made various grades of recommendations for the clinical diagnosis and treatment of gastric cancer to reflect the value of cancer treatment and meeting health economic indexes. This guideline uses tables and is complemented by explanatory and descriptive notes covering the diagnosis, comprehensive treatment, and follow-up visits for gastric cancer.

引用

页数：31

共 155 条

[21] Capecitabine and oxaliplatin for advanced esophagogastric cancer [J].

Cunningham, David ;

Starling, Naureen ;

Rao, Sheela ;

Iveson, Timothy ;

Nicolson, Marianne ;

Coxon, Fareeda ;

Middleton, Gary ;

Daniel, Francis ;

Oates, Jacqueline ;

Norman, Andrew Richard .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (01) :36-46

[22] Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J].

Cunningham, David ;

Allum, William H. ;

Stenning, Sally P. ;

Thompson, Jeremy N. ;

Van de Velde, Cornelis J. H. ;

Nicolson, Marianne ;

Scarffe, J. Howard ;

Lofts, Fiona J. ;

Falk, Stephen J. ;

Iveson, Timothy J. ;

Smith, David B. ;

Langley, Ruth E. ;

Verma, Monica ;

Weeden, Simon ;

Chua, Yu Jo .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) :11-20

[23] Preoperative treatment and surgery in gastric cancer: friends or foes? [J].

D'Ugo, Domenico ;

Rousei, Stefano ;

Biondi, Alberto ;

Persiani, Roberto .

LANCET ONCOLOGY, 2009, 10 (02) :191-195

[24] New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].

Eisenhauer, E. A. ;

Therasse, P. ;

Bogaerts, J. ;

Schwartz, L. H. ;

Sargent, D. ;

Ford, R. ;

Dancey, J. ;

Arbuck, S. ;

Gwyther, S. ;

Mooney, M. ;

Rubinstein, L. ;

Shankar, L. ;

Dodd, L. ;

Kaplan, R. ;

Lacombe, D. ;

Verweij, J. .

EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247

[25] Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer [J].

Eom, Bang Wool ;

Joo, Jungnam ;

Kim, Young-Woo ;

Reim, Daniel ;

Park, Ji Yeon ;

Yoon, Hong Man ;

Ryu, Keun Won ;

Lee, Jong Yeul ;

Kook, Myeong-Cherl .

SURGERY, 2014, 155 (03) :408-416

[26]

Expert Committee on Safety Management of Anti-neoplastic Drugs of Chinese Society of Clinical Oncology, 2015, CANC CHIN CLIN ONCOL, V2, P841

[27] Long-term benefits of Roux-en-Y pouch reconstruction after total gastrectomy - A randomized trial [J].

Fein, Martin ;

Fuchs, Karl-Hermann ;

Thalheimer, Andreas ;

Freys, Stephan M. ;

Heimbucher, Johannes ;

Thiede, Arnulf .

ANNALS OF SURGERY, 2008, 247 (05) :759-765

[28] Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial [J].

Fuchs, Charles S. ;

Doi, Toshihiko ;

Jang, Raymond W. ;

Muro, Kei ;

Satoh, Taroh ;

Machado, Manuela ;

Sun, Weijing ;

Jalal, Shadia I. ;

Shah, Manish A. ;

Metges, Jean-Phillipe ;

Garrido, Marcelo ;

Golan, Talia ;

Mandala, Mario ;

Wainberg, Zev A. ;

Catenacci, Daniel V. ;

Ohtsu, Atsushi ;

Shitara, Kohei ;

Geva, Ravit ;

Bleeker, Jonathan ;

Ko, Andrew H. ;

Ku, Geoffrey ;

Philip, Philip ;

Enzinger, Peter C. ;

Bang, Yung-Jue ;

Levitan, Diane ;

Wang, Jiangdian ;

Rosales, Minori ;

Dalal, Rita P. ;

Yoon, Harry H. .

JAMA ONCOLOGY, 2018, 4 (05)

[29] Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial [J].

Fuchs, Charles S. ;

Tomasek, Jiri ;

Yong, Cho Jae ;

Dumitru, Filip ;

Passalacqua, Rodolfo ;

Goswami, Chanchal ;

Safran, Howard ;

dos Santos, Lucas Vieira ;

Aprile, Giuseppe ;

Ferry, David R. ;

Melichar, Bohuslav ;

Tehfe, Mustapha ;

Topuzov, Eldar ;

Zalcberg, John Raymond ;

Chau, Ian ;

Campbell, William ;

Sivanandan, Choondal ;

Pikiel, Joanna ;

Koshiji, Minori ;

Hsu, Yanzhi ;

Liepa, Astra M. ;

Gao, Ling ;

Schwartz, Jonathan D. ;

Tabernero, Josep .

LANCET, 2014, 383 (9911) :31-39

[30] Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial [J].

Fujitani, Kazumasa ;

Yang, Han-Kwang ;

Mizusawa, Junki ;

Kim, Young-Woo ;

Terashima, Masanori ;

Han, Sang-Uk ;

Iwasaki, Yoshiaki ;

Hyung, Woo Jin ;

Takagane, Akinori ;

Park, Do Joong ;

Yoshikawa, Takaki ;

Hahn, Seokyung ;

Nakamura, Kenichi ;

Park, Cho Hyun ;

Kurokawa, Yukinori ;

Bang, Yung-Jue ;

Park, Byung Joo ;

Sasako, Mitsuru ;

Tsujinaka, Toshimasa .

LANCET ONCOLOGY, 2016, 17 (03) :309-318

← 1 2 3 4 5 6 7 8 9 10 →